FDLI Annual Conference

Goodwin is a proud sponsor of the premier conference for the food and drug law community, the FDLI Annual Conference. This conference will address complex legal, regulatory, compliance, and policy issues in all facets of the FDA-regulated industry. The conference provides in-depth discussions and analyses on a wide variety of timely topics by bringing together experts from the federal government, industry, the private bar, non-profit, patient and consumer advocates, consulting organizations, and academia.

Goodwin partner and FDA Litigation practice co-chair Brian Burgess will be a featured speaker on the panel, "Interchangeable Biosimilars – Emerging Legal Issues and Trends."